[New antineoplastic antibiotics, new analogs, modifiers of biological reactions and oncogene inhibitors].
Viadro
M M
MM
Navashin
S M
SM
D000276:Adjuvants, Immunologic; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D016227:Benzoquinones; D001761:Bleomycin / Q000627:therapeutic use; D004341:Drug Evaluation; D006801:Humans; D047029:Lactams, Macrocyclic; D051379:Mice; D008937:Mitomycins / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology; D009374:Neoplasms, Experimental / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology; D009857:Oncogenes / Q000187:drug effects*; D011809:Quinones / Q000627:therapeutic use*; D017828:Rifabutin / Q000031:analogs & derivatives
D000276:Adjuvants, Immunologic; D000903:Antibiotics, Antineoplastic; D016227:Benzoquinones; D047029:Lactams, Macrocyclic; D008937:Mitomycins; D011809:Quinones; D001761:Bleomycin; D017828:Rifabutin; C020754:herbimycin
Novye protivoopukholevye antibiotiki, novye analogi, modifikatory biologicheskikh reaktsiĭ, ingibitory onkogenov.